Dalbavancin Therapy for Infective Endocarditis

Clinical trial NCT07699211 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07699211
Sponsor: Stefan Hagel
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Endocarditis Infective Endocarditis, Bacterial

Start date: 2026-12-01
Primary completion: 2028-09-01
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.